Hide Board Information

Show Board Information

NORDDEUTSCHE LANDESBANK GIROZENTRAL 4.5% INST 23/4/13 EUR1000 64EU

Board Mod: Add me as mod

Asst Mods:

Last Post: 06/04/2012 2:03:26 AM

Board Marks: 0

Posts Today: 0

Board Views Today: 1

NORDDEUTSCHE LANDESBANK GIROZENTRAL 4.5% INST 23/4/13 EUR1000 (64EU) Stock Message Board

Find 64EU Recent News, 64EU Filings, 64EU Stock Quote, 64EU Stock Chart, 64EU Research & Opinions Below

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

Be the first to post on NORDDEUTSCHE LANDESBANK GIROZENTRAL 4.5% INST 23/4/13 EUR1000 64EU

Recent Articles

• Wood Pulp Market Growth Forecast – Key Trends and Drivers
• Conduit Pharmaceuticals Partners to Harness AI for Drug Development
• Valour Unveils 20 Innovative Digital Asset ETPs at Once
• Discover Good Supply's Exciting New Holiday Cannabis Launches
• Exciting Advances in Chronic ITP Treatment with TAVALISSE®
• Safety Shot Anticipates Impressive Revenue Surge Ahead
• Innovative Drone-Powered Quantum Computing for Smarter Cities
• Repligen's 2023 Sustainability Report: A Commitment to Impact
• Concordia University Expands Research Opportunities with Funding
• Medicus Pharma Explores Innovative Treatments with FDA Support
• Voting Procedures and Meeting Materials for Mega View Digital
• Wiley Increases Quarterly Dividend to Support Shareholders
• Important Update on UAB Orkela Bondholders Meeting Venue
• Monterey County DA's Office Integrates NICE Justice for Digital Evidence
• XTM Partners with Pateno Payments for Major Investment Move
• Unlocking Sales Success: Varicent's GenAI Assistants Are Here
• Turnitin Ranks Among Top Businesses in Education Industry
• Keepit Emerges as a Leading SaaS Data Protection Provider
• Conagra Brands Unveils Upcoming Dividend Announcement
• Allegiant Travel Company Sees Strong November Passenger Traffic
• Exro's First Cell Driver™ System Installation Showcases Innovation
• Chronograph Partners with Carta for Enhanced Equity Insights
• Trevi Therapeutics Maintains Sample Size in Key IPF Trial
• Elevation Oncology Enhances ADC Pipeline with EO-1022 Development
• Elevation Oncology Partners with Synaffix for ADC Innovation
• Future of HR Payroll Software: Market Growth Insights Ahead
• Gaxos.ai Enhances Game Development with Recraft AI Solutions
• Exploring the Future of Wax Warmers & Accessories Market Growth
• Innovative Product Launches Drive SRM Entertainment's Expansion
• Future Growth Projections for the Cutaneous T-Cell Lymphoma Market
• Innovations Driving the Bladder Cancer Detection Kit Market Growth
• Kadant’s 2024 Investor Day: Pioneering Sustainable Solutions
• Bullet Blockchain and Sailo Technologies Team Up for Security
• Netcompany's Share Buyback Program: Recent Transactions Summary
• UK Business Leaders Adapt Strategies Amid AI and Global Changes
• Mike Morse Law Firm Embraces Keeper Security for Cyber Defense
• Transforming Staffing Solutions with TrueBlue's JobStack App
• Hamilton Zanze Expands Portfolio with Strategic Investment in Freddie Mac
• Bidgely Boosts AI-Powered Solutions and Revenue Growth
• Waylens Partners with Greater Than for Enhanced Fleet Safety
• C.H. Robinson Gears Up for a Prominent Investor Day Revealing Future Strategies
• BDR Launches New Training Series for Service Managers
• NextRNA Welcomes Dr. Charles Kunsch to Board of Directors
• Frontera Energy's 2025 Production Strategy and Capital Insights
• Ciena Elevates Lawton W. Fitt as New Board Chair Leadership
• Exploring the Impact of Effective Communication Strategies
• Terradot's Innovative Approach and Funding Transform Carbon Removal
• Rio Tinto's Significant Investment in Rincon Lithium Expansion
• Atikamekw First Nation and NMG Join Forces on Mining Deal
• Gambling.com Group Acquires Odds Holdings to Boost Growth